8-K current report · filed Sep 28, 2026

Kimberly-Clark (KMB) 8-K Current Report: September 28, 2026

Item 8.01Item EX-99.1Item EX-99.2Item EX-99.3Item EX-99.4KMB overview

Short answer

Kimberly-Clark (KMB) filed an 8-K current report with the SEC on September 28, 2026 reporting Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2), Item EX-99.3 (Exhibit EX-99.3), Item EX-99.4 (Exhibit EX-99.4). Exchange offer targets all outstanding Kenvue Notes for up to $7.0 billion of new Kimberly-Clark notes plus cash.

Kimberly-Clark 8-K event analysis

AI summary of each reported item and its exhibits

Item 8.01 · Other Events

  • Exchange offer targets all outstanding Kenvue Notes for up to $7.0 billion of new Kimberly-Clark notes plus cash
  • Consent solicitations would remove most Kenvue debt covenants, selected default triggers, SEC reporting requirements, and merger restrictions
  • Offers conditioned on First Merger completion, expected in fourth-quarter 2026
  • Pro forma financials and Kenvue audited and interim statements provide investor visibility into the combined company’s potential profile
  • Pro forma results are informational and not predictive of post-merger financial performance

Item EX-99.1 · Exhibit EX-99.1

  • Exchange offers cover up to $7.0 billion of Kenvue notes, contingent on completing the acquisition in fourth quarter 2026
  • Early tenders receive $970 Kimberly-Clark notes, $30 premium and $1 cash per $1,000 Kenvue notes
  • Kimberly-Clark assumes unsecured senior debt with matching rates, maturities, payment dates and redemption terms
  • Consent solicitations would remove most Kenvue noteholder protections, including restrictive covenants and certain default triggers
  • Early participation deadline October 9, 2026; offers expire October 27, 2026; withdrawal deadline October 9, 2026

Item EX-99.2 · Exhibit EX-99.2

  • Audited Kenvue financials cover fiscal years through December 28, 2025, with PwC issuing an unqualified opinion
  • FY2025 net sales $15.124B, down from $15.455B, while net income rose to $1.470B from $1.030B
  • Operating income $2.414B, helped by lower impairment charges, despite $290M restructuring expense
  • Operating cash flow $2.197B supported $1.581B dividends, $475M capital spending and $197M share repurchases
  • Kimberly-Clark merger advanced: shareholder approvals obtained, antitrust waiting period expired, foreign regulatory approvals remain outstanding

Item EX-99.3 · Exhibit EX-99.3

  • Kenvue Q2 net sales $3,955M, up from $3,839M, supporting the pending Kimberly-Clark combination with modest topline growth
  • Six-month operating income $1,466M versus $1,250M, while net income rose to $930M from $742M
  • Operating cash flow reached $1,177M, funding $796M of dividends and $245M of capital spending
  • Pending merger consideration: 0.14625 Kimberly-Clark shares plus $3.50 cash per Kenvue share
  • Regulatory risk remains: shareholder approvals and U.S. antitrust clearance completed, but foreign approvals still required

Item EX-99.4 · Exhibit EX-99.4

  • Pro forma merger combines K-C and Kenvue, with K-C holders owning approximately 54% and Kenvue holders approximately 46%
  • Expected fourth-quarter 2026 closing remains subject to regulatory approvals and customary conditions
  • Pro forma 2025 sales $31.483B and net income attributable to K-C $2.109B
  • Financing includes expected $4.9B permanent debt, with pro forma long-term debt reaching $18.223B
  • Preliminary purchase accounting adds $22.994B of intangible assets and $4.061B of goodwill, creating valuation and future amortization risk

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Kimberly-Clark 8-K filings

Get the next KMB 8-K as it lands

Follow KMB for push alerts, or ask the research agent what this filing means.